FIELD: biotechnology.
SUBSTANCE: invention relates to a low-toxic (E)-2-(4-{[3-(2,4-dimethoxyphenyl)acrylamido]methyl}-1H-1,2,3-triazole-1-yl)-2-isopropyl-9-(4-methyl piperazine-1-yl)-3,7-dioxo-3,7-dihydro-2H-furo[3,2-g]chromen of formula (I) , having the analgesic activity in the test "acetic acid-induced writhing". The said property enables to use this compound in medicine.
EFFECT: compound of formula I is prepared from furocoumarin peucedanine contained in the plant Peucedanum morisonii.
1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
3-ARYL-4A-ISOPROPYL-4AN-CHROMENO[6',7':4,5]FURO[3,2-C][1,2]OXAZINE-8-ONES WITH ANTI-INFLAMMATORY AND ANALGETIC ACTIVITY | 2016 |
|
RU2622768C1 |
(1S,4a,5S,6R)-METHYL-5{2-[1-(2-AMINO-2-OXOETHYL)-2-OXOPYRROLIDIN-3-YL]ETHYL}-1,4a,6-TRIMETHYLDECAHYDRONAPHTHALENE-1-CARBOXYLATE, HAVING ANTICONVULSANT AND ANALGESIC ACTIVITY | 2008 |
|
RU2385864C2 |
USE OF 5-ARYL-4-AROYL-3-HYDROXY-1-CARBOXYMETHYL-3-PYRROLIN-2-ONES AS ANALGESICS | 2023 |
|
RU2816900C1 |
USE OF 4-[1-(4-METHYLPHENYL)AMINOETHYLIDENE]-5-PHENYL-1-CYANOMETHYLTETRAHYDROPYRROLE-2,3-DIONE AS AN ANALGESIC | 2023 |
|
RU2806330C1 |
APPLICATION OF 2-HYDROXY-3-METHYL-6-(1-METHYLETHENYL)CYCLOHEX-3-ENONE AS ANALGESIC | 2010 |
|
RU2421213C1 |
2-(6-ARYL-4-AROYL-3-METHYL-1-PHENYL-1H-PYRAZOLO[3,4-b]PYRIDIN-5-YL)-2-OXO-N-ARYLACETAMIDES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2501800C2 |
1-HEXADECYL-4,6-DIMETHYL-2-OXONICOTINAMIDE EXHIBITING ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY | 2008 |
|
RU2396258C2 |
METHYL 4-HYDROXY-4-METHYL-6-PHENYL-2-CYANOACETYLHYDRAZONOCYCLOHEXANE-1-CARBOXYLATE EXHIBITING ANALGESIC ACTIVITY | 2010 |
|
RU2446150C2 |
ETHYL 4-(5-BENZOYL-6-(4-(DIETHYLAMINO)PHENYL)-4-HYDROXY-2-THIOXOHEXAHYDROPYRIMIDIN-4-CARBOXAMINO)BENZOATE, EXHIBITING ANALGESIC AND ANTI-INFLAMMATORY ACTION | 2019 |
|
RU2717246C1 |
2-(1-(2-(2-CHLORO-10H-PHENOTHIAZIN-10-YL)-2-OXOETHYL)-5-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENOL, HAVING HYPOTENSIVE AND ANTIARRHYTHMIC ACTIVITY | 2008 |
|
RU2394823C2 |
Authors
Dates
2015-04-27—Published
2014-03-13—Filed